We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Erlotinib
Australian Public Assessment Report
Device/Product Name
Tarceva
Active ingredients
Erlotinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2011-01993-3-4
Submission Type
Extension of indications
Decision
Approved